Home ProductsNootropic Powder

High Purity Nootropic Powder , 99% IDRA 21 Powder CAS 22503-72-6 IDRA -21

Certification
Good quality Peptide APIs for sales
Good quality Peptide APIs for sales
Customer Reviews
Good Price .Product is by far the besT, very pleased and happy, wil buy again.

—— K******s United Kingdom

High Purity, fast shipping ,recomended this company.

—— Perry*****t United State

Great service I was kept informed about my order the whole time Thanks Jones.

—— E****y Australia

I'm Online Chat Now

High Purity Nootropic Powder , 99% IDRA 21 Powder CAS 22503-72-6 IDRA -21

China High Purity Nootropic Powder , 99% IDRA 21 Powder CAS 22503-72-6 IDRA -21 supplier
High Purity Nootropic Powder , 99% IDRA 21 Powder CAS 22503-72-6 IDRA -21 supplier High Purity Nootropic Powder , 99% IDRA 21 Powder CAS 22503-72-6 IDRA -21 supplier

Large Image :  High Purity Nootropic Powder , 99% IDRA 21 Powder CAS 22503-72-6 IDRA -21

Product Details:

Place of Origin: China
Brand Name: MOBELBIO
Certification: ISO,SGS

Payment & Shipping Terms:

Price: 1
Packaging Details: Foil Bag
Delivery Time: Within 1-3 Days
Payment Terms: T/T
Supply Ability: 50Kgs/Month
Contact Now
Detailed Product Description

 

High Purity Nootropics 99% IDRA 21 Powder CAS: 22503-72-6 IDRA-21

 

 

High Purity Nootropic Powder , 99% IDRA 21 Powder CAS 22503-72-6 IDRA -21

Product Name: IDRA-21

CAS No.: 22503-72-6
Package:1g/bag, 100g/bag, 1kg/bag, 25kg/drum or other quantity just as you requests.
Molecular formula: C8H9ClN2O2S
Molecular weight: 232.68700
Density: 1.394g/cm3
Boiling point: 405.1oC at 760mmHg
Flash point: 198.8oC
Refractive index: 1.571
Steam pressure: 8.98E-07mmHg at 25°C

Function of IDRA-21

IDRA-21 is a relatively new nootropic compound.

IDRA-21 works as an ampakine stimulant drug and is currently being researched in regards to IDRA-21 effects in memory improvement, cognitive enhancement, stimulation, and reversing cognitive deficits.

IDRA-21 is likely it was developed in 1994 or 1995 as the first clinical trials and peer-reviewed research articles appear in the literature in 1995.

 

Application

 

IDRA-21 is an ampakine drug and a benzothiadiazine derivative. IDRA-21 is a chiral molecule, with (+)-IDRA-21 being the active form.
IDRA-21 shows nootropic effects in animal studies, significantly improving learning and memory.

IDRA-21 is around 10–30 times more potent than aniracetam in reversing cognitive deficits induced by scopolamine, and produces sustained effects lasting for up to 48 hours after a single dose. The mechanism for this action is thought to be through promoting the induction of long-term potentiation between synapses in the brain.
IDRA-21 does not produce neurotoxicity under normal conditions, although it may worsen neuronal damage following global ischemia after stroke or seizures.
In comparison to the benzoylpiperidine derived ampakine drugs, IDRA-21 was more potent than CX-516, but less potent than CX-546. Newer benzothiadiazide derivatives with greatly increased potency compared to IDRA-21 have been developed, but these have not been researched to the same extent, with the benzoylpiperidine and benzoylpyrrolidine CX-series of drugs being favoured for clinical development, most likely due to more favourable toxicity profiles at high doses.

 

 

Item Inspection Standard

 

Appearance

 

Off white solid powder

 

Identification

 

Conform with NMR

 

Melting Point

149-152°C

 

Loss on Drying

≤0.50%
Residue on ignition ≤1.0%

 

Purity(HPLC)

 

≥99%

 

Heavy metals

 

NMT 20PPM


Other product list

NSI-189

PRL-8-53

IDRA-21

Coluracetam

Fasoracetam

Sunifiarm

Unifiram

Contact Details
HANGZHOU MOBEL BIOTECHNOLOGY CO.,LTD

Contact Person: admin

Send your inquiry directly to us (0 / 3000)